SUN PHARMACEUTICAL INDUSTRIES INC recalls medroxyPROGESTERone Acetate Injectable Suspension, USP, 25 x 1 mL Single-Dose Vial, 150 mg/mL, Rx only, Distributed by:
Recalled June 22, 2022 · FDA recall D-1147-2022 · SUN PHARMACEUTICAL INDUSTRIES
Hazard
Lack of assurance of sterility · FDA Class II
Units
26892 vials
Sold at
USA Nationwide
Description
Lack of assurance of sterility
Product
medroxyPROGESTERone Acetate Injectable Suspension, USP, 25 x 1 mL Single-Dose Vial, 150 mg/mL, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd., Halol Baroda Highway, Halol-389 350, Gujarat India , NDC 16714-090-40 packaged in 25 count carton.
Manufacturer(s)
SUN PHARMACEUTICAL INDUSTRIES INC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →